BWS Financial Inc

BWS provides independent stock specific research focused on companies with distinct value that are going through a special situation where there is a tangible catalyst not priced in. The catalyst can be anything from new product, restructuring, M&A, management change, change in business strategy, etc. BWS’s focus is to understand the change and evaluate the potential return for investors.

BWS utilizes a self formed proprietary approach in discovering stocks by putting great emphasis on deep research. BWS does generate short recommendations following a similar criteria.

Independent Stock Specific Research

ASRT: Updated Q4 Results Puts 2023 in Focus

Founder, BWS Financial Inc

Hamed Khorsand

Founder

Equity Bottom-Up

<ul>
<li>ASRT has completed a convertible note offering providing financial flexibility in management's pursuit of purchasing pharmaceutical assets.</li>
<li>ASRT's limited financial history of generating positive free cash flow limits available options</li>
<li>The timing of the debt offering without a deal announced poses the possibility of limiting ASRT's stock price appreciation</li>
</ul>


ASRT has completed a convertible note offering providing financial flexibility in management's pursuit of purchasing pharmaceutical assets.
ASRT's limited financial history of generating positive free cash flow limits available options
The timing of the debt offering without a deal announced poses the possibility of limiting ASRT's stock price appreciation


ASRT: Convertible Offering Pauses Momentum

Assertio Holdings

ASRT: Convertible Offering Pauses Momentum